A research letter by Uscher-Pines et al. surveyed 2,009 US adults on GLP-1 use and alcohol. He flags important caveats in reading the results.
Recap by typeshit. Post by Dr Ahmad Rehan Khan on X.
Dr Alo, a cardiologist, says he is following the cardiovascular data on these drugs closely and that it is shifting how heart disease is treated.
50:28
DOWNSIZED looks at why appetite and food noise can creep back late in the weekly cycle, and what that may say about whether a GLP-1 is still working.
Avi Roy points to trial data on drugs like Ozempic, including a 16-week study of 73 people where milkshake ratings barely changed despite reduced appetite.
Research presented at the anesthesiology meeting linked GLP-1 use with lower odds of heart attack and other heart problems. It shows an association, not proof of cause.
Shea reports all four known activators sat deep in the receptor pocket while both blockers stayed farther out, the same pattern as his first small test.
A busy week in Mexico also covered IMSS workers rejecting a 6.8% raise. GLP-1 drugs get a mention for shifting what people buy to eat.
Loading…